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Abstract: Chronic non-healing wounds are a clinically important problem in terms of number of
patients and costs.  Wound dressings such as hydrogels, hydrocolloids, polyurethane
films and foams are commonly used to manage these wounds since they tend to
maintain a moist environment which is shown to accelerate re-epithelialization. The
use of antibacterial compounds is important in the management of wound infections.
A novel wound-dressing material based on a blended matrix of the polysaccharides
alginate, hyaluronic acid and Chitlac-silver nanoparticles is here proposed and its
application for wound healing is examined. The manufacturing approach to obtain
membranes is based on gelling, foaming and freeze-casting of alginate, hyaluronic
acid and Chitlac-silver nanoparticles mixtures using calcium ions as the cross-linking
agent. Comprehensive evaluations of the morphology, swelling kinetics, permeability,
mechanical characteristics, cytotoxicity, capability to inhibit metalloproteinases and of
antibacterial property were conducted.  Biological in vitro studies demonstrated that
hyaluronic acid released by the membrane is able to stimulate the wound healing
meanwhile the metal silver exploits an efficient antibacterial activity against both
planktonic bacteria and biofilms.  Overall, the experimental data evidence that the
studied material could be used as antibacterial wound dressing for wound healing
promotion.
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Abstract  
Chronic non-healing wounds are a clinically important problem in terms of number of patients 
and costs.  Wound dressings such as hydrogels, hydrocolloids, polyurethane films and foams 
are commonly used to manage these wounds since they tend to maintain a moist environment 
which is shown to accelerate re-epithelialization. The use of antibacterial compounds is 
important in the management of wound infections. 
A novel wound-dressing material based on a blended matrix of the polysaccharides alginate, 
hyaluronic acid and Chitlac-silver nanoparticles is here proposed and its application for wound 
healing is examined. The manufacturing approach to obtain membranes is based on gelling, 
foaming and freeze-casting of alginate, hyaluronic acid and Chitlac-silver nanoparticles 
mixtures using calcium ions as the cross-linking agent. Comprehensive evaluations of the 
morphology, swelling kinetics, permeability, mechanical characteristics, cytotoxicity, 
capability to inhibit metalloproteinases and of antibacterial property were conducted.  
Biological in vitro studies demonstrated that hyaluronic acid released by the membrane is able 
to stimulate the wound healing meanwhile the metal silver exploits an efficient antibacterial 
activity against both planktonic bacteria and biofilms.  Overall, the experimental data evidence 
that the studied material could be used as antibacterial wound dressing for wound healing 
promotion. 
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1.Introduction 
The cascade of events leading to a non-healing wound is not well defined, although several 
features of the impaired physiological process have been discovered [1]. These wounds are 
characterized by a prolonged inflammation [2, 3], an inhibited proliferative activity [4, 5], a 
defective migration of keratinocytes and a modified fibroblasts function with passage from a 
synthetic phenotype to a degrading and senescent phenotype [6]. Senescent fibroblasts cause 
defects on ExtraCellular Matrix (ECM) integrity because the production of high levels of 
proteolytic enzymes and of decreased levels of MMPs’ inhibitors [7-9]. 
A key problem associated with chronic non-healing wounds is drug-resistant infection because 
the skin barrier functionality has been compromised. The bacteria strains isolated from chronic 
wounds are mainly Staphylococcus, Enterococcus and Pseudomonas [10]. Co-existence of 
aerobic and anaerobic bacteria and biofilm formation can contribute to create a drug-resistance 
infection that escapes the host immune response [11, 12]. 
Although treatments of chronic wounds can differ slightly, the most common ones consist in   
removing damaged and necrotic tissue, reducing tissue exudates and minimizing pain [13-15]. 
Wound dressings such as hydrogels, hydrocolloids, polyurethane films and foams are 
commonly used since they tend to maintain a moist environment that was shown to accelerate 
re-epithelialization and create a physical barrier that reduces bacterial contamination [16, 17]. 
Alginate dressings appear to be particular effective in the management of highly exuding 
wounds. The topical and systemic administration of antibiotics constitutes the main clinical 
practice to prevent and treat bacterial infections in these wounds. 
However, the rising antibiotic-resistance of bacteria requires the use of new broad-spectrum 
antibacterial agents [18]. Silver has been proposed as a bactericidal agent in wound 
management. Wound dressing containing silver in different forms like ions, nanocrystalline 
silver, inorganic complexes and silver sulfadiazine are described in the scientific literature  [19-
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21] and some products are available on the market (e.g. Aquacel® Ag from Convatech, 
Acticoat™ from Smith and Nephew, UrgoTul® Ag/Silver from Urgo Medical). Their 
effectiveness has been ascribed to silver release [22]. 
Travan et al. [23] reported the production of well-dispersed silver nanoparticles (AgNPs) by 
chemical reduction of silver ions in the presence of a lactose-modified chitosan (Chitlac). 
Embedding  the nanocomposite system Chitlac-AgNPs into alginate and chitosan gels results 
in anti-bacterial and non-cytotoxic biomaterials [23-26]. 
Hyaluronic Acid (HA) is a bioactive molecule with a wide range of biological functions such 
as stimulation of cell proliferation, differentiation, migration and angiogenesis [27, 28], 
modulation of inflammation and of the immune cells function [29]. The beneficial effects of 
HA released by alginate-based membranes on viability and migration of human primary 
fibroblasts and keratinocytes have been already demonstrated by Travan et al.[30]. 
In this work, we describe a pliable and porous alginate-based membrane in which Chitlac-
AgNPs and HA are combined together to endow the material with biological properties 
exploitable in the treatment of non-healing wounds. The membrane is produced by foaming, 
gelling and freeze-casting a ternary mixture of alginate, HA and Chitlac-AgNPs; the material 
is characterized in terms of physical-chemical, mechanical and biological properties. This 
material is designed to combine the bioactive properties of HA and the bactericidal activity of 
silver nanoparticles in a foamed alginate matrix. 
 
2.Materials and methods 
2.1Materials 
Chitlac (lactose-modified chitosan, CAS number 85941-43-1) was synthesized starting from 
commercial chitosan from Sigma-Aldrich (degree of acetylation 18%) as reported by Donati et 
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al.. [31]. The composition of Chitlac was determined by means of 1H-NMR and resulted to be: 
glucosamine residues 20%, N-acetyl-glucosamine 18% and 2-(lactit-1-yl)-glucosamine 62%. 
The relative Molecular Weight (MW) of Chitlac is around 1.5x106.  
Alginate from Laminaria hyperborea (Alginate Pronova UP LVG; MW= 120 000; fraction of 
guluronic residues, FG = 0.69; fraction of guluronic diads, FGG = 0.59; number average of G 
residues in G-blocks, NG>1 = 16.3) was kindly provided by Novamatrix/FMC Biopolymer 
(Sandvika, Norway). The sodium hyaluronate (Phylcare Sodium Hyaluronate extra LW) was 
purchased from Biophil Italia Spa (MW ≈ 100 - 400 kDa). 
Hydroxy-methyl-2-propyl cellulose (HMPC, CAS number 9004-65-3, Pharmacoat 603, 
substitution type 2910) was purchased from Shin-Etsu (Tokyo, Japan).  
Calcium carbonate (CaCO3), D-Gluconic acid δ-lactone (GDL), glycerol (ReagentPlus® ≥ 
99.0%), silver nitrate (AgNO3), ascorbic acid, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic 
acid (HEPES), EDTA, Mitomycin C, 2-(N-Morpholino)ethanesulfonic acid (MES), sodium 
chloride (NaCl), sodium bicarbonate (NaHCO3), hydrochloric acid (HCl), MTT formazan 
powder [1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan], glucose, ethanol, Hanks’ 
Balanced Salt solution (HBSS, product code H8264), phosphate buffered saline (PBS), Luria 
Bertani (LB) broth, LB Agar and Brain Heart Infusion (BHI) broth were purchased from Sigma-
Aldrich (Chemical Co. U.S.A). 
Dulbecco’s Modified Eagle’s Medium high glucose and fetal bovine serum were from 
Euroclone (Italy). AlamarBlue® Cell Viability Reagent, Medium106 and Low Serum Growth 
supplement was purchased from Life Technologies. MMP activity assay Kit (Fluorimetric-
Green), MMP-9 and MMP-2 recombinant enzymes were from Abcam®. 
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2.2Synthesis of silver nanoparticles 
Silver nanoparticles were prepared using Chitlac as a stabilizing agent as reported by Travan et 
al. [23]; briefly, Chitlac 4 g/L was dissolved in deionized water and the solution was added with 
AgNO3 2 mM and ascorbic acid 1 mM (final concentrations), incubated overnight at room 
temperature in the dark and subsequently stored at 4°C.  
2.3Manufacturing of membranes  
The membranes were prepared according to the following procedure: alginate (8 g/L) and HA 
(4 g/L) were completely dissolved in water and then HEPES buffer pH 7 to final concentration 
0.01 M was added. Chitlac-AgNPs solution (2 g/L of polymer final concentration), HPMC (4 
g/L) and glycerol (5% V/V) were then added. An in situ gelation of the mixture was obtained 
by the addition of CaCO3 (20 mM) and GDL (40 mM). Immediately after GDL addition, the 
solution was foamed for 30 seconds and its aliquots were cured in tissue culture plates for 24 h 
at room temperature to allow complete gelification. The hydrogels were then step-wise cooled 
by immersion in a liquid cryostat. Temperature was decreased stepwise from 20 to -20 °C by 5 
°C steps with 30 minutes’ intervals; the samples were then freeze-dried.  
2.4Mechanical characterization  
 Mechanical characterization was done according to ASTM D638 standards – by using a 
Universal Testing Machine (Multitest Mecmesine 2.5-i) with load cell of 100 N.  The 
membranes were carved with a cutter into dog-bone shape and gripped with metallic clamps. 
Tensile tests were performed on dry membranes at a crosshead speed of 5 mm/min. Tensile 
stress was calculated dividing the load by the average original cross sectional area in the gage 
length segment of the specimen. Young’s Modulus was calculated as the slope of the linear 
portion in the stress-strain curve, considering the deformation range of 1%-3%. For each 
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formulation, five replicates were used, the data were averaged and standard deviations 
calculated.  
2.5Scanning electron microscopy (SEM) analysis 
Morphological analysis of the freeze-casted membranes was performed with a Leica-
Stereoscan 430i Scanning Electron Microscope. In environmental conditions, membrane 
specimens were sputter-coated with gold prior to observation. 
2.6Swelling tests 
Freeze-casted membranes were cut into pieces of 20 mm of diameter, weighed and immersed 
in 10 mL of HBSS. After 1, 2, 10, 30, 45 and 60 minutes, materials were blotted for 1 minute 
on a filter paper and weighted. The swelling ratio was calculated as the ratio between the weight 
at time X and the initial dry weight at time 0, following the equation:  
 
2.7Water-vapor transmission rate 
For determining the ability of the membranes to transmit vapor, ASTM E96 standard test 
method for Water Vapor Transmission of materials was used.  
Glass bottles with a top closure of 16 mm of diameter were filled with mQ water in order to 
have 2 cm of distance between the water and the sample, closed with a round shaped piece of 
membrane sample of 17 mm of diameter and sealed laterally with Parafilm®. The bottle was 
weighted and incubated for 24 and 48 hours at 32 ± 0.4 °C and 45 ± 2 % humidity. At the end 
of the incubation time the bottle was weighed.  
Commercially available dressings were used as control samples: Connettivina plus® (Fidia 
farmaceutici S.p.A.) and Chitoderm™ (Pietrasanta Pharma S.p.A.). Furthermore, uncapped 
0timeatWeight
timeatWeight
ratioSwelling x
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bottles and bottles capped with Parafilm were used as control of free evaporation and no 
evaporation, respectively. 
Water vapor transmission rate was calculated according to the formula:  
hA
WW
hmgWVTR
24*
)/( 0242

  
where: 
W24 = weight at 24 hours (in grams),  
W0 = initial weight of the filled and capped bottle (in grams), 
A = area of the top closure of the bottle (in m2). 
 
Four replicates were performed per each sample and the analysis was done by calculating 
average and standard deviation of samples both at 24 and 48 hours. 
2.8Silver release  
For the quantification of released silver, 60 mg of membrane composed of alginate 8 g/L, HA 
4 g/L, Chitlac-AgNPs 2 g/L, HPMC 4 g/L, glycerol 5 %, CaCO3 20 mM, and GDL 40 mM was 
immersed in 3 mL of HBSS for 2, 24, 72 hours and 7 days at 37 °C. At the defined time the 
membrane was removed from HBSS solution to which 0.5 mL NH4OH 1 N solution was added 
in order to solubilize silver precipitates (release solution). The membrane was washed in 3 mL 
of HBSS for 2 minutes and, after membrane removing, 0.5 mL NH4OH 1 N was added to the 
solution. Both release solution and washing solution were used for the measurement. 
Membranes without Chitlac-AgNPs (45 mg) and composed of alginate 8 g/L, HA 4 g/L, HPMC 
4 g/L, glycerol 5%, CaCO3 20 mM, GDL 40 mM) were used as control samples.  
 Measurements were performed by Electro-Thermal Atomic Absorption Spectrometry 
(ETAAS) with Zeeman background correction. A Thermo M series AA spectrometer equipped 
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with a GF95Z Zeeman Graphite Furnace and a FS95 Furnace Autosampler (Thermo Electron 
Corporation, Cambridge, UK) was used for analysis.  
The obtained values have been compared with a calibration curve calculated with a standard 
solution of silver (Silver ICP/DCP-Sigma Aldrich). The limit of detection (LOD) at the 
analytical wavelength of 328.1 nm was 0.5 μg/L and the precision of the measurements as 
repeatability (RSD %) for the analysis was always less than 5%. 
Data analysis was performed by summing the silver found in the release solution and the 
washing solution. The values were express as percentage of silver released in comparison with 
the total amount of silver contained in the membrane (148 µg/60 mg of membrane). 
2.9Antimicrobial tests 
To assess the antimicrobial activity three different bacterial strains were used: Staphylococcus 
aureus (ATCC® 25923™), Staphylococcus epidermidis (ATCC® 12228™) and Pseudomonas 
aeruginosa (ATCC® 27853™).  Two different protocols were employed: bacterial growth 
inhibition assay and biofilm eradication assay. 
Bacterial growth inhibition assay: 
Membrane samples were cut into pieces of 40 mg and sterilized under UV rays. Bacteria were 
inoculated in Luria Broth medium (LB) and incubated for 16 hours at 37 °C.  After 16 h, 500 
µL of bacterial suspension was diluted in 10 mL of LB and grown up for 120 min at 37 °C in 
order to restore an exponential growth phase. The optical density at 600 nm was measured in 
order to assess bacterial concentration. Bacteria were diluted to 5x106 CFU/mL in 10% (V/V) 
LB in PBS and 1 mL of bacteria was added to each sample and incubated for 24 hours at 37°C. 
Tests were carried out in shaking condition (140 rpm) to optimize the contact between bacteria 
and membranes. At the end of the incubation time, bacterial suspensions were diluted in PBS 
and each suspension was spread on LB agar. After overnight incubation at 37 °C, the colony 
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forming units (CFU) were counted. A suspension of bacteria grown in liquid medium was used 
as control.  
Biofilm eradication assay:  
S. aureus and P. aeruginosa were inoculated in Brain Heart Infusion (BHI) broth plus 3 % w/V 
sucrose and incubated for 16 hours at 37 °C. Bacteria were then diluted 1:100 in the same broth 
and seeded (300 μL/well) into 24-well plates for 48 hours in static conditions at 37 °C. Broth 
was then removed and biofilm was carefully rinsed twice with 100 μL of sterile PBS in order 
to remove non-adherent cells. 300 μL of PBS were added to each well and circular specimens 
of membranes (40 mg) were deposited on the bacterial layer and incubated for 24 hours. MTT 
assay was then performed according to Brambilla et al. (Brambilla et al., 2012). Briefly, MTT 
stock solution was prepared by dissolving 5 mg/mL of MTT powder in PBS and sterilized by 
filtration. Membranes and PBS were gently removed from the plates and each well was 
carefully rinsed three times with 100 μL of PBS. 200 µL of MTT solution (prepared by mixing 
0.5 mL of MTT stock solution and 4.5 mL of sterile PBS) were placed into each well and the 
plates were incubated for 3 h under lightproof conditions at 37 °C. The MTT solution was then 
gently removed and formazan crystals were dissolved by adding 200 µL of DMSO to each well. 
Plates were stored for 1 h under lightproof conditions at room temperature, then 80 μL of the 
solution were transferred into the wells of a 96-well plate and, absorbance was measured using 
a spectrophotometer (Infinite M200 PRO NanoQuant, Tecan) at a wavelength of 550 nm. 
Outcomes were expressed as optical density (O.D.) units. 
For confocal laser scanning microscopy (LSCM) analyses of biofilm, bacteria were seeded on 
sterile 13 mm tissue culture coverslips (Sarstedt, U.S.A.) placed inside a 24-well plate. After 
biofilm growth and its treatment with membranes as described above, FilmTracer Live/Dead 
biofilm viability kit (Invitrogen™) was used for biofilm staining following the manufacture’s 
protocol. Images were acquired on a Nikon Eclipse C1si confocal laser-scanning microscope 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 11 
 
with a Nikon Plan Fluor 20X as objective. Resulting stacks of images were analyzed using 
ImageJ software. The ratio between red and green signals was calculated as: 













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Green
d
treatedNon
Green
d
Sample
rateNormalized
Re
Re
 
where: 
Red = means grey value of the red channel 
Green = means grey value of the green channel 
 
2.10Cell culture 
Primary human dermal fibroblasts (HDFa) were purchased from GibcoTM. Cells were grown in 
Medium 106 supplemented with Low Serum Growth supplement, 100 U/mL penicillin, and 
100 μg/mL streptomycin.  
Human keratinocyte cell line HaCaT (kindly gifted by Dr. Chiara Florio, University of Trieste) 
was grown in Dulbecco’s Modified Eagle’s Medium high glucose, 10% heat-inactivated fetal 
bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin and 2 mM L-glutamine.  Cells 
were maintained at 37 °C in a humidified, 5 % CO2 environment. 
2.11Cytotoxicity test  
Evaluation of cellular toxicity of membranes was performed according to ISO10993-5 
specifications by direct-contact test.  
Membranes were cut using biopsy punches into cylinders of 4 mm of diameter and sterilized 
under UV-rays.  
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HDFa and HaCaT cells were seeded in 24-well plates at a density of 2x104 cells per well and 
16 hours later, test samples were placed directly on the cell layer for 24 and 72 hours. Samples 
were then removed, cells were washed in PBS and 250µL of Alamar Blue dye diluted 1:10 in 
culture medium was added and incubated for 4 hours. 100 µL of Alamar solution were 
transferred onto a 96-well microtiter plate and fluorescence was measured with a microplate 
reader (Tecan Infinite® M100 Pro) at ex 544nm / em 616 nm. As positive control material, 
polyurethane films (PU) containing 0.25% zinc dibuthyldithiocarbamate (ZDBC) (6 mm disks) 
were used (Hatano Research Institute / Food and Drug Safety Center Reference Material Office 
- Japan). As a negative control material, polystyrene sheets (PS) (6 mm disks) were used (Wako 
Pure Chemical Industries).  
2.12Scratch wound healing assay 
UV-sterilized membrane samples were placed in Dulbecco’s modified Eagle’s medium, FBS 
10%, penicillin 100 U mL-1, streptomycin 100 μg mL-1 and L-glutamine 2 mM for 24 h at      
37 °C (extract medium). The ratio between sample weight and medium volume was 15 mg/mL 
for the membrane without Chitlac-AgNPs and 20 mg/mL for the membrane with Chitlac (ChM 
membranes) and with Chitlac-AgNPs (SM membranes).  
HDFa and HaCaT cells were seeded in 6-well plates at a density of 2.5x105 and 3.5 x105 cells, 
respectively, and incubated at 37 °C until reaching a confluent monolayer. Cells were then 
treated with extract medium. Each treatment was performed in duplicate. 24 hours after 
treatment cell layers were wounded by scratching with a 200 µl pipette tip and the scratch 
closure was followed over time through an Olympus CK2 Inverted Microscope (Phase 
Condenser ULWCD 0.3) equipped with a camera Canon PowerShot A630. The images of the 
scratch were acquired over time to monitor the wound closure. The analysis was performed 
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using software Image J: the region of interest (ROI) was outlined per each scratch and the 
percentage of closure over time was plotted. For each treatment, eight images were analyzed.  
2.13Matrix Metalloproteinases activity assay 
MMPs activity was determined by using the MMP Activity Assay Kit following the 
manufacture’s protocol. Recombinant MMP-2 and MMP-9 enzymes were activated by 
treatment with 1 mM 4-Aminophenylmecuric Acetate (APMA) for 1 h and 2 h, respectively 
and used in the reaction mixture at the concentration 1 U/L.   
For MMPs extraction, HDFa and HaCaT were lysed in PBS by freeze-thaw cycles using a dry 
ice/ethanol bath and a water bath at 37°C. MMP enzymes present in HDFa and HaCaT lysates 
were activated with 1 mM APMA for 3 hours at 37 °C.  
Chitlac and Chitlac-AgNPs were pre-incubated 20 minutes at RT with recombinant MMPs or 
cell lysates before addition of the substrate solution supplied by the manufacturer of the kit. 
After 1 h of incubation with substrate at RT, endpoint measurement was performed at λex 490 
nm and λem 525 nm with a Tecan Infinite® M100 Pro plate reader.  
 
 
3. Results  
 
3.1Material preparation and characterization 
The employed method for the manufacturing of the membranes consists of gelling a foamed 
solution composed of alginate, HA, a colloidal suspension of antimicrobial silver nanoparticles 
coordinated by the polymer Chitlac (Chitlac-AgNPs), HPMC and glycerol (as the plasticizer), 
followed by freeze casting the resulting hydrogel (Figure 1). The experimental conditions to 
obtain the miscibility of the oppositely charged polysaccharides (namely Chitlac, alginate and 
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HA), avoiding polymer phase separation, have been already explored in previous studies of this 
group [32]. 
The hydrogel was formed by the use of Ca2+ ions (derived from CaCO3 dissociation by 
acidification of the solution) which homogeneously cross-link the alginate chains.  
After freeze-drying, the gel became a soft, flexible and spongy membrane (Figure 1). The 
orange-brown color is produced by the combination of the specific size (i.e. 35 nm) and of the 
spectroscopic properties of the silver nanoparticles. It should be noticed that, owing to the 
procecure devised, such material can be easily produced with the desired dimensions or cut in 
different shapes to match the wound shape and size. 
For the sake of clarity, the resulting membranes will be named in the manuscript as “SM” when 
containing silver (in the form of the Chitlac-AgNPs system), as “ChM” when containing Chitlac 
(without silver nanoparticles), and as “CM” when containing neither Chitlac nor silver 
nanoparticles. 
The foamed membrane was analyzed by electron microscopy in the dry state both as top view 
and as cross-section. Figure 2 reports the SEM images of SM and CM membranes. In both 
cases, the cross section shows a highly porous structure while the top view shows a smooth 
surface. 
An ideal wound dressing material must have good tensile strength because the dressing should 
not be damaged by handling procedures and must withstand the stress resulting from skin 
movements without rupturing. 
The stiffness (Young’s Modulus), the resistance (stress at break) and the deformation (strain at 
break) of the material were then studied by uniaxial tensile tests; the results are reported in 
Figure 3. 
The results revealed that, in the presence of Chitlac-AgNPs (SM), the material displays lower 
strength and deformation at break as compared with the membrane without Chitlac-AgNPs 
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(CM): this could be reasonably ascribed to the destabilizing role of the polycation Chitlac with 
respect to the alginate cross-linked matrix. However, in the range of small (elastic) 
deformations, the Young’s modulus of SM and CM membranes are comparable.  
3.2Reswelling and water vapor transmission rate studies 
The reswelling behavior of SM was studied in HBSS buffer. Figure 4a reports the liquid uptake 
expressed as a variation over time of the normalized weight (weight of the membrane at tx over 
weight of the dry membrane). It can be observed that within the first minute of soaking the 
material weight underwent a six-fold increase.   
After the initial liquids uptake, the slow decrease of membrane weight can be ascribed to the 
slow release of HA, in line with the data previously reported by Travan et al. (2016) [30]. 
WVTR (Water Vapor Transmission Rate) was measured for the SM membrane, as well as for 
the ChM and CM membranes. Their thickness was 3 mm. WVTR is defined as the transmission 
of the water vapor per unit time through a unit area of the tested material. Two commercially 
available membranes were used as control samples: Connettivina plus® (Fidia farmaceutici 
S.p.A.) is a highly permeable gauze soaked with hyaluronic acid while Chitoderm™ 
(Pietrasanta Pharma S.p.A.) is a chitosan-containing pad with a polyurethane layer which limits 
water permeability. The results are reported in Figure 4b.  
The SM membrane has a WVTR (78.5 ± 2.6 g/m2h) comparable with that of ChM and CM 
membranes. Moreover, the WVTR of these membranes are comparable with the WVTR of 
Connettivina plus®. As expected, the WVTR of Chitoderm™ is much lower (20.8 ± 1.2 g/m2h) 
than that of the other samples.  
3.3Silver release studies 
The amount of silver released from the membranes was quantified by Electro-Thermal Atomic 
Absorption Spectrometry (ETAAS). 
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A progressive, albeit very low, release of silver can be seen over time (Figure 5). The silver 
released from membranes is only a minimal fraction of the total content of silver: after one 
week, only 0.9% of the total silver is leaked, indicating that most of the metal is firmly 
entrapped inside the material, which represents a potential reservoir for a long-term slow release 
of the antimicrobial compound. Similar results were described also by Travan et al. for alginate 
hydrogels containing Chitlac-AgNPs [23]. It is noteworthy to observe that the capability of the 
polymeric matrix to stabilize silver particles is an important feature to avoid  an excessively 
fast release of silver in the physiological environment, thus limiting potential toxic effects 
towards eukaryotic cells [23]. 
 
3.4 Antibacterial activity against planktonic bacteria and mature biofilms 
The antimicrobial activity on planktonic bacteria was tested on Staphylococcus aureus, 
Staphylococcus epidermidis and Pseudomonas aeruginosa by incubating the bacterial 
suspension with the membranes for 24 hours. The Colony Forming Units per milliliter (Log 
CFU mL-1) calculated for each sample after 24 hours are reported in Figure 6.  
In Figure 6 it can be observed that the SM membrane induces a significant decrease of CFUs 
for all the bacterial strains tested, in comparison with the growth of bacteria treated with the 
CM membrane. More specifically, there is a decrease of 3.5, 5.6 and 4.8 Log CFU mL-1 for S. 
aureus, S. epidermidis, P. aeruginosa, respectively.  
There is a significant difference also between the bacteria in plain broth and the bacteria treated 
with the SM membrane. In detail, there is a decrease of 3.1, 3.5 and 4.8 Log CFU mL-1 for        
S. aureus, S. epidermidis, and P. aeruginosa, respectively.  
Bacteria growing into biofilms are metabolically very different from planktonic bacteria and 
often display a high antibiotic resistance [11]. Antibacterial tests on mature biofilms have been 
then performed: Figure 7 pointed out the results obtained after 24 h of treatment of P. 
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aeruginosa and S. aureus biofilms with the antibacterial membrane. In both cases, the 
antibacterial activity is preserved even when bacteria grow into biofilms. The optical density 
after MTT assay is twice lower for biofilms treated with the membrane containing silver 
compared with the control membrane. 
To confirm the data obtained via MTT assay, bacterial viability in the biofilms was visualized 
by fluorescence confocal microscope after treatment with the Live/Dead staining assay. 
Biofilms were grown into glass coverslips and treated for 24 hours with the membranes. After 
Live/Dead staining, images were acquired and analyzed calculating the ratio between the red 
signals (dead cells) and the green signal (living cells) both for the treated sample and the non-
treated sample as shown in Figure 8. 
The Live/Dead assay confirmed data from MTT assay: in the biofilm treated with the silver-
containing membrane, there is a significant increase of the ratio between red and green signal 
compared to the non-treated biofilms. The difference is definitely higher for S. aureus biofilms 
(ratio value = 3.2) than for P. aeruginosa (ratio value = 1.85).  
3.5 Viability of cells treated with membranes  
In order to assess the in vitro biocompatibility of SM membranes for dermatological 
applications, their toxicity was tested by the Alamar Blue assay using human primary 
fibroblasts (HDFa) and a keratinocyte cell line (HaCaT). Sterilized membranes were applied 
by direct contact on the cells and the analysis were performed after 24 and 72 hours. As a 
positive control of cell death, cells treated with a toxic material (Pb/Zn) were considered. Figure 
9 shows the results on HDFa and HaCaT cells, respectively.  
The result pointed out that 24 and 72 h after treatment, the products released from SM sterilized 
membranes did not affect cell viability. The growth rate of the cells treated with the SM 
membranes is not significantly different from that of the cells in contact with the membranes 
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without silver (ChM) and in contact with the negative control material (PS). On the contrary, a 
dramatic and significant decrease of growth rate is observed for the cells treated with the 
positive control material (Pb/Zn).   
3.6Scratch test on cells treated with components released from membranes  
Travan et al. demonstrated that HA released from the alginate matrix during the first hours of 
soaking in physiological solutions promotes in vitro fibroblast proliferation and migration [30]. 
To confirm also for the SM membranes the wound healing effect in vitro, scratch tests were 
performed on both keratinocytes (HaCaT) and fibroblasts (HDFa) treated with the components 
released from membranes in culture medium. Confluent monolayers of cells were scratched as 
described in the Methods and then allowed to re-epithelialize for 48 h at 37 °C. The percentage 
of scratch closure over time is shown in Figure 10 for both HDFa and HaCaT cells. The 
behavior of the cells treated with the extracts from SM and ChM membranes can be considered 
as comparable, indicating that the presence of the metal does not impair the positive biological 
response. For HaCaT cells, after 24 hours from the treatment, there is a significant difference 
between cells treated with the membrane containing Ag and the non-treated cells (75% vs. 56% 
of gap closure, respectively, with p-value < 0.05). Also HDFa cells, exposed to SM membranes, 
showed significantly improved scratch closure (p-value < 0.01) after 24 and 30 hours in 
comparison with the control. In former case the gap closure was 60% after 24 hours and almost 
100% after 32 hours, while in the control the gap closure was 40% and 87% at 24 and 32 hours, 
respectively. 
Overall, the data indicates that HA released from the SM membrane can support the 
physiological healing process. 
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3.7 MMPs activity assay  
The influence of Chitlac-AgNPs on MMPs activity was then studied both on total MMPs 
extracted from cells and on purified MMP-2 and MMP-9 enzymes (Figure 11). 
Chitlac-AgNPs are more efficient to influence MMP-2 activity rather than MMP-9 and they 
display an inhibition efficacy more pronounced than that exerted by Chitlac alone, used as 
control.   
 
4.Discussion 
The biomaterial proposed in this work is based on the modification and implementation of a 
protocol used for the preparation of alginate/hyaluronic acid membranes recently published by 
some authors of this paper [30];  that material was designed to release HA, as a bioactive 
polysaccharide, from the 3D solid-like architecture of the calcium-alginate structure to promote 
the healing of tissues. 
Based on the above mentioned paper, the present study is aimed at implementing such 
membranes with additional bioactive components for the specific management of infected non-
healing wounds. The resulting reticulated matrix was meant to provide the physical structure 
for the entrapment of silver nanoparticles coordinated by Chitlac and the release of the bioactive 
component HA upon contact with the target tissue.  
The process of foaming aims at creating a spongy structure to enable a high uptake of water 
and to increase the extension of the bactericidal surface.  
HPMC was chosen as foaming agent because of its biocompatibility and its use in the 
preparation of porous alginate-based matrices [33]. The concentration of HPMC was selected 
by testing cell viability at different concentrations of HPMC inside the membranes (data not 
shown). The HA here used (MW 240 000) was previously selected between a range of HA with 
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different molecular weights. HA 240 000 was shown to stimulate proliferation of fibroblasts 
and keratinocytes and migration of fibroblasts [30].  
All the three polysaccharides (alginate, hyaluronic acid and Chitlac) used for membrane 
preparation are very hydrophilic polymers because of the presence of a large number of 
hydrophilic groups such as hydroxyl, carboxyl and amino groups. It was so not unexpected to 
observe that in water solution the polymeric structure rapidly absorbed a high amount of liquid 
(Figure 4a). Hydrophilic dressings able to efficiently absorb large amount of fluids have been 
shown to possess a key role in the treatment of highly exudative wounds. A wound requires a 
moist but not wet environment for proper functioning of the cells responsible for wound healing 
and to avoid wound margin maceration [34]. Moreover, the absorption of the wound fluids by 
the dressing promotes the entrapment of colonizing bacteria inside the membrane matrix where 
antibacterial agents like silver nanoparticles can exert their bactericidal activity.   
Besides the capability of swelling in contact with fluids, an important requisite of a wound 
dressing is a suitable water vapor transmission rate (WVTR), adequate to maintain a moist 
environment, without risking dehydration or exudates accumulation. The biomaterial should 
keep a balance between presence of liquid and water evaporation [35].  
Commercial dressings have been shown to cover a very large spectrum of WVTR, ranging from 
90 (Dermiflex®, Johnson&Johnson) to 3350 g/m2 /day (Beschitin®, Unitika). Clearly, the 
WVTR is related to the structural properties (thickness, porosity) of the dressing as well as to 
the chemical composition of the material. However, WVTR within the range 2000 – 2500 
g/m2day have been claimed by Queen et al. as the ideal rate (half of that of a granulating wound) 
that a wound dressing should possess to provide adequate level of moisture without risking 
wound dehydration  [36]. The SM membrane described in this paper displays an average 
WVTR of 1920 g/m2/day (Figure 4b), which matches with reasonable approximation the 
WVTR value range indicated by Queen et al.[36]. 
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The silver-release test (Figure 5) points out the successful entrapment of the nanoparticles 
inside the membrane and the low release of free silver ions, evidenced also by the lack of 
cytotoxicity of the material (Figure 9). The potential cytotoxicity of silver, both as ions or 
nanoparticles, is a big concern to be given much attention when this metal is used for its 
antibacterial features. Despite the large use of this compound in silver dressing, delivering of 
the metal into tissues can result in toxic effects on growing keratinocytes and fibroblasts. 
Paddle-Ledinek et al. reported cytotoxicity of extracts of some commercial silver-containing 
dressings (Acticoat, Aquacel-Ag, Contreet-H, and Avance) when exposed to keratinocyte 
cultures [37]. 
Besides chronic infections, excess of proteolytic enzymes is one of the major issues of the 
chronic non-healing wound since it shifts the balance of matrix synthesis towards its 
degradation, so impairing the granulation tissue formation. MMPs activity in chronic wounds 
is thirty times higher than the MMPs activity in acute wounds [38]. In particular, elevated levels 
of MMP-2 and MMP-9 have been found in chronic wounds [38-40]. Selective inhibition of 
MMPs at the wound site by a dressing is considered an efficient way in achieving a fast tissue 
healing [41]. The, albeit weak, inhibiting effects that Chitlac exerts on MMPs is not surprising 
since also chitosan is described to reduce peptidolytic activity of these enzymes, in particular 
of MMP2. A possible mechanism for the reduction of the activity of MMPs by chitosan is a 
direct molecular interaction between the enzyme and the polysaccharide [42, 43]. 
It should be stressed that our findings show a quantifiable higher inhibitory effect of Chitlac-
AgNPs on MMPs with respect to Chitlac alone (see Figure 11): in fact, in the former case, the 
presence of the metal seems to play a leading role to reduce the proteinase activity. Indeed, the 
use of silver-containing wound care products has been already reported to reduce MMP activity 
both in vitro and in vivo, although the mechanism for remains unclear. One explanation may 
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be the displacement of zinc ions by silver (ions) from the proteolytic enzyme, [44, 45] the Ag+ 
ions deriving from the nanoparticle reservoir. 
 
5. Conclusions 
Chronic non-healing wounds are a great clinical problem that is expected to become more 
serious due to the increasing duration of life and thus the increasing number of people affected 
by diseases correlated with chronic non-healing wounds. Despite a number of products in the 
form of membranes, gels and pomades are available in the market [46], there is continuous need 
of biocompatible biomaterials with a wide spectrum of antimicrobial efficacy and with the 
capability to prevent biofilm formation, while at the same time stimulating wound closure.  
In this work, a wound dressing material based on alginate, hyaluronan and Chitlac-nAg was 
successfully designed and manufactured in the form of a pliable membrane by using a technical 
procedure that could be easily scaled-up.  
The membrane was shown to support in vitro the healing process and to be effective against 
both planktonic bacteria and bacterial biofilms. This feature makes them appealing for the 
prevention of bacteria colonization as well as for the treatment of infected sites. Moreover, the 
component Chitlac-AgNPs was demonstrated to inhibit in vitro the proteolytic activity of 
MMPs, whose overexpression is shown to impair the recommencement of healing in 
recalcitrant wounds. 
In vitro biological studies on the biocompatibility of the membrane on a keratinocyte cell line 
and on primary fibroblasts showed that the membranes are non-cytotoxic. This behavior can be 
ascribed to the very low rate of silver release over time due to the effective nanoparticles 
stabilization within the polysaccharide network. 
The reswelling kinetic studies demonstrated that the biomaterial is highly hygroscopic, an 
important feature in the perspective to remove excessive exudates containing bacteria nutrients 
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from the wound beds. At the same time, the membranes possess a good water-vapor 
transmission rate (WVTR) value, which could ensure a moist environment on the wound beds, 
without risking dehydration or exudates accumulation. The membranes are flexible and can be 
easily cut into the desired shape. Overall, this novel biomaterial appears particularly suited to 
contrast the drawbacks of chronic non-healing wounds and so to support tissue regeneration.  
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Figure captions 
Fig.1 Sketch of the procedure to obtain foamed membranes containing Chitlac-AgNPs (left) 
and image of a membrane with cut edge where the internal spongy structure and the flexibility 
of the material can be observed (right) 
Fig. 2 SEM images of SM (lower figures) and CM membranes (upper figures) 
Fig. 3 Mechanical properties of the foamed membranes (SM and CM membranes): Young’s 
modulus (left), stress at break (center) and strain at break (right). Data are expressed as mean ± 
st.dv. with n = 5 
Fig. 4  a) Reswelling behavior of SM membranes. Data are expressed as mean ± st.dv. with n 
= 4. b) WVTR of membranes and of commercial samples (Connettivina plus® and 
Chitoderm™). No capped bottles and bottles capped with parafilm were used as control for free 
evaporation and no evaporation. Data are expressed as mean ± st.dv. with n = 6 
Fig. 5 Silver release from the SM membrane over time. Data are expressed as percentage of the 
total silver contained into the membrane. Data are mean ± st.dv. with n = 3 
Fig. 6 Growth rate expressed as Log CFU mL-1 of S. aureus (a), S.epidermidis (b) and P. 
aeruginosa (c) following 24 h of treatment with SM membranes, ChM membrane and grown 
in plain culture medium.  Data are expressed as mean ± st.dv. with n = 3. For statistical analysis, 
samples treated with SM membrane were compared with samples treated with ChM membrane. 
In the Student’s test *** indicate p < 0.001 
Fig. 7 Viable biomass MTT assay expressed as O.D. at 550 nm of P. aeruginosa (a) and S. 
aureus (b) following 24 h of treatment with SM and ChM membranes. For statistical analysis, 
samples treated with SM membrane were compared to samples treated with ChM sample. In 
the Student’s test * indicate p < 0.1; ** indicate p < 0.05 
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Fig. 8 Live/Dead assay for P. aeruginosa (a) and S. aureus (b) biofilms treated with SM 
membranes: the graphs show the ratio between the red (propidium iodide, indicating dead cells) 
and the green signal (Syto9, indicating living cells) normalized over the non-treated sample 
Fig. 9 In vitro cytoxicity tests of HDFa (left) and HaCaT cells (right) treated with membranes 
by direct contact. PS represents the negative control and ZDBC the positive control. Data are 
expressed as mean ± st.dv. with n = 4. For statistical analysis (Student’s test), samples treated 
with SM and ChM membrane were compared to samples treated with negative control (PS) 
Fig. 10 Scratch assay using human dermal fibroblasts (HDFa) and keratinocytes cells (HaCaT) 
cultured in absence and presence of extracts from ChM and SM membranes. Data represent 
means ± st.dv. Statistically significant differences were calculated with a paired student t-test 
with n=8; *p<0.05, **p<0.01 
Fig. 11  MMPs activity in presence of Chitlac-AgNPs (ChAg) or Chitlac (Ch): (a) effects on 
MMP-2; (b) Effects on MMP-9; (c) Effects on MMPs extracted from fibroblasts (HDFa cells); 
and (d) effects on MMPs extracted from keratinocytes (HaCaT cells). Data are expressed as 
mean ± st.dv. with n=4. Ch = Chitlac, ChAg = Chitlac-AgNPs. The percentage of enzyme 
inhibition is calculated in comparison with the enzyme activity in the absence of polymers. 
Statistically significant differences were calculated with a paired student t-test with *p<0.05, 
**p<0.01 
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